194 related articles for article (PubMed ID: 24107628)
1. Cyclin D1 is a major target of miR-206 in cell differentiation and transformation.
Alteri A; De Vito F; Messina G; Pompili M; Calconi A; Visca P; Mottolese M; Presutti C; Grossi M
Cell Cycle; 2013 Dec; 12(24):3781-90. PubMed ID: 24107628
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of microRNA-95-3p suppresses brain metastasis of lung adenocarcinoma through downregulation of cyclin D1.
Hwang SJ; Lee HW; Kim HR; Song HJ; Lee DH; Lee H; Shin CH; Joung JG; Kim DH; Joo KM; Kim HH
Oncotarget; 2015 Aug; 6(24):20434-48. PubMed ID: 25971210
[TBL] [Abstract][Full Text] [Related]
3. Levels matter: miR-206 and cyclin D1.
Crescenzi M
Cell Cycle; 2013 Dec; 12(24):3715. PubMed ID: 24189536
[No Abstract] [Full Text] [Related]
4. Circular RNA circ-CMPK1 contributes to cell proliferation of non-small cell lung cancer by elevating cyclin D1 via sponging miR-302e.
Cui D; Qian R; Li Y
Mol Genet Genomic Med; 2020 Feb; 8(2):e999. PubMed ID: 31863641
[TBL] [Abstract][Full Text] [Related]
5. Guanidinoacetic Acid Regulates Myogenic Differentiation and Muscle Growth Through miR-133a-3p and miR-1a-3p Co-mediated Akt/mTOR/S6K Signaling Pathway.
Wang Y; Ma J; Qiu W; Zhang J; Feng S; Zhou X; Wang X; Jin L; Long K; Liu L; Xiao W; Tang Q; Zhu L; Jiang Y; Li X; Li M
Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30235878
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-195 inhibits the proliferation of human glioma cells by directly targeting cyclin D1 and cyclin E1.
Hui W; Yuntao L; Lun L; WenSheng L; ChaoFeng L; HaiYong H; Yueyang B
PLoS One; 2013; 8(1):e54932. PubMed ID: 23383003
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-545 suppresses cell proliferation by targeting cyclin D1 and CDK4 in lung cancer cells.
Du B; Wang Z; Zhang X; Feng S; Wang G; He J; Zhang B
PLoS One; 2014; 9(2):e88022. PubMed ID: 24505359
[TBL] [Abstract][Full Text] [Related]
8. NF-kappaB controls cell growth and differentiation through transcriptional regulation of cyclin D1.
Guttridge DC; Albanese C; Reuther JY; Pestell RG; Baldwin AS
Mol Cell Biol; 1999 Aug; 19(8):5785-99. PubMed ID: 10409765
[TBL] [Abstract][Full Text] [Related]
9. Homeobox Transcription Factor NKX2-1 Promotes
Harada M; Sakai S; Ohhata T; Kitagawa K; Mikamo M; Nishimoto K; Uchida C; Niida H; Kotake Y; Sugimura H; Suda T; Kitagawa M
Mol Cancer Res; 2017 Oct; 15(10):1388-1397. PubMed ID: 28634225
[TBL] [Abstract][Full Text] [Related]
10. Epigenetically altered miR-193b targets cyclin D1 in prostate cancer.
Kaukoniemi KM; Rauhala HE; Scaravilli M; Latonen L; Annala M; Vessella RL; Nykter M; Tammela TL; Visakorpi T
Cancer Med; 2015 Sep; 4(9):1417-25. PubMed ID: 26129688
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-503 suppresses proliferation and cell-cycle progression of endometrioid endometrial cancer by negatively regulating cyclin D1.
Xu YY; Wu HJ; Ma HD; Xu LP; Huo Y; Yin LR
FEBS J; 2013 Aug; 280(16):3768-79. PubMed ID: 23731275
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-551b-3p inhibits tumour growth of human cholangiocarcinoma by targeting Cyclin D1.
Chang W; Wang Y; Li W; Shi L; Geng Z
J Cell Mol Med; 2019 Aug; 23(8):4945-4954. PubMed ID: 31199052
[TBL] [Abstract][Full Text] [Related]
13. miR-211 suppresses epithelial ovarian cancer proliferation and cell-cycle progression by targeting Cyclin D1 and CDK6.
Xia B; Yang S; Liu T; Lou G
Mol Cancer; 2015 Mar; 14():57. PubMed ID: 25889927
[TBL] [Abstract][Full Text] [Related]
14. miR-218 suppresses gastric cancer cell cycle progression through the CDK6/Cyclin D1/E2F1 axis in a feedback loop.
Deng M; Zeng C; Lu X; He X; Zhang R; Qiu Q; Zheng G; Jia X; Liu H; He Z
Cancer Lett; 2017 Sep; 403():175-185. PubMed ID: 28634044
[TBL] [Abstract][Full Text] [Related]
15. Akt-p53-miR-365-cyclin D1/cdc25A axis contributes to gastric tumorigenesis induced by PTEN deficiency.
Guo SL; Ye H; Teng Y; Wang YL; Yang G; Li XB; Zhang C; Yang X; Yang ZZ; Yang X
Nat Commun; 2013; 4():2544. PubMed ID: 24149576
[TBL] [Abstract][Full Text] [Related]
16. MiR-146a-5p inhibits cell proliferation and cell cycle progression in NSCLC cell lines by targeting CCND1 and CCND2.
Li YL; Wang J; Zhang CY; Shen YQ; Wang HM; Ding L; Gu YC; Lou JT; Zhao XT; Ma ZL; Jin YX
Oncotarget; 2016 Sep; 7(37):59287-59298. PubMed ID: 27494902
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-202 induces cell cycle arrest and apoptosis in lung cancer cells through targeting cyclin D1.
Jiang J; Huang J; Wang XR; Quan YH
Eur Rev Med Pharmacol Sci; 2016 Jun; 20(11):2278-84. PubMed ID: 27338052
[TBL] [Abstract][Full Text] [Related]
18. Diacylglycerol kinase δ controls down-regulation of cyclin D1 for C2C12 myogenic differentiation.
Sakai H; Murakami C; Matsumoto KI; Urano T; Sakane F
Biochimie; 2018 Aug; 151():45-53. PubMed ID: 29859210
[TBL] [Abstract][Full Text] [Related]
19. CDK3 is a major target of miR-150 in cell proliferation and anti-cancer effect.
Wang L; Xi Y; Sun C; Zhang F; Jiang H; He Q; Li D
Exp Mol Pathol; 2017 Apr; 102(2):181-190. PubMed ID: 28108217
[TBL] [Abstract][Full Text] [Related]
20. miR-449a Regulates proliferation and chemosensitivity to cisplatin by targeting cyclin D1 and BCL2 in SGC7901 cells.
Hu J; Fang Y; Cao Y; Qin R; Chen Q
Dig Dis Sci; 2014 Feb; 59(2):336-45. PubMed ID: 24248414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
